Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - USD ($)
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2019 $ 13 $ 344,029 $ 31,259,365 $ (55,682,264) $ (24,078,857)
Beginning Balance, Shares at Dec. 31, 2019 13,000 34,402,944      
Share-based compensation from issuance of options and compensation-based warrants 25,614 25,614
Exercise of stock options $ 8,177 63,419 71,596
Exercise of stock options, Shares 817,732      
Net Loss 5,438,024 5,438,024
Ending Balance at Mar. 31, 2020 $ 13 $ 352,206 31,348,398 (50,244,240) (18,543,623)
Ending Balance, Shares at Mar. 31, 2020 13,000 35,220,676      
Beginning Balance at Dec. 31, 2020 $ 13 $ 358,499 37,139,854 (66,232,439) (28,734,073)
Beginning Balance, Shares at Dec. 31, 2020 13,000 35,850,089      
Share-based compensation from issuance of options and compensation-based warrants 102,000 102,000
Shares issued upon reverse split to avoid fractional shares $ 19 (19)
Shares issued upon reverse split to avoid fractional shares, Shares 1,793      
Conversion of note payable to shares $ 15,868 460,168 476,036
Conversion of note payable to shares, Shares 1,586,786      
Net Loss (8,221,174) (8,221,174)
Ending Balance at Mar. 31, 2021 $ 13 $ 374,386 $ 37,702,003 $ (74,453,613) $ (36,377,211)
Ending Balance, Shares at Mar. 31, 2021 13,000 37,438,668